Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease in Adolescents and Adults

NCT00357669 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Unverricht-Lundborg Disease

Interventions

DRUG: Brivaracetam 25 mg
DRUG: Brivaracetam 50 mg
OTHER: Placebo

Sponsor

UCB Pharma SA